TIXiMED

Birmingham, United States

TIXiMED is a biotechnology company that develops and commercialises medicines for diabetes treatment.

$2.6M raised

Dec 2024

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TIXiMED raised?

TIXiMED has raised $2.6M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2024.

Who are TIXiMED's investors?

TIXiMED's investors include The Leona M. and Harry B. Helmsley Charitable Trust.

Where is TIXiMED headquartered?

TIXiMED is headquartered in Birmingham, United States.

What does TIXiMED do?

TIXiMED is a biotechnology company that develops and commercialises medicines for diabetes treatment.

What stage is TIXiMED at?

TIXiMED is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2024.

MLA

"TIXiMED — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/tiximed. Accessed July 1, 2026.

APA

VCBacked. (2024). TIXiMED — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/tiximed

Wikipedia (cite web)

{{cite web |title=TIXiMED — Funding & Investors |url=https://www.vcbacked.co/company/tiximed |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2024.